Literature DB >> 17696221

Hepatorenal syndrome.

Sharon Turban1, Paul J Thuluvath, Mohamed G Atta.   

Abstract

Hepatorenal syndrome (HRS) is a "functional" and reversible form of renal failure that occurs in patients with advanced chronic liver disease. The distinctive hallmark feature of HRS is the intense renal vasoconstriction caused by interactions between systemic and portal hemodynamics. This results in activation of vasoconstrictors and suppression of vasodilators in the renal circulation. Epidemiology, pathophysiology, as well as current and emerging therapies of HRS are discussed in this review.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17696221      PMCID： PMC4205304          DOI： 10.3748/wjg.v13.i30.4046

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


  66 in total

1.  Which patients benefit from hemodialysis therapy in hepatorenal syndrome?

Authors:  Oliver Witzke; Markus Baumann; Daniel Patschan; Susann Patschan; Anna Mitchell; Ulrich Treichel; Guido Gerken; Thomas Philipp; Andreas Kribben
Journal:  J Gastroenterol Hepatol       Date:  2004-12       Impact factor: 4.029

2.  Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study.

Authors:  Richard Moreau; Francois Durand; Thierry Poynard; Christian Duhamel; Jean-Paul Cervoni; Philippe Ichaï; Armand Abergel; Chantal Halimi; Mathieu Pauwels; Jean-Pierre Bronowicki; Emile Giostra; Cathy Fleurot; Danielle Gurnot; Olivier Nouel; Philippe Renard; Michel Rivoal; Pierre Blanc; Dimitri Coumaros; Sylvie Ducloux; Stephane Levy; Alexandre Pariente; Jean-Marc Perarnau; Jean Roche; Myriam Scribe-Outtas; Dominique Valla; Brigitte Bernard; Didier Samuel; Joël Butel; Antoine Hadengue; Andrzej Platek; Didier Lebrec; Jean-Francois Cadranel
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

3.  Renal failure in patients with cirrhosis of the liver. 3. Evaluation of intrarenal blood flow by para-aminohippurate extraction and response to angiotensin.

Authors:  E T Schroeder; L Shear; S M Sancetta; G J Gabuzda
Journal:  Am J Med       Date:  1967-12       Impact factor: 4.965

Review 4.  Antidiuretic hormone and the pathogenesis of water retention in cirrhosis with ascites.

Authors:  V Arroyo; J Clària; J Saló; W Jiménez
Journal:  Semin Liver Dis       Date:  1994-02       Impact factor: 6.115

5.  The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites.

Authors:  Georgios Kalambokis; Michalis Economou; Andreas Fotopoulos; Jihad Al Bokharhii; Christos Pappas; Afroditi Katsaraki; Epameinondas V Tsianos
Journal:  Am J Gastroenterol       Date:  2005-04       Impact factor: 10.864

6.  Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.

Authors:  E Akriviadis; R Botla; W Briggs; S Han; T Reynolds; O Shakil
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

7.  Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome.

Authors:  A Hadengue; A Gadano; R Moreau; E Giostra; F Durand; D Valla; S Erlinger; D Lebrec
Journal:  J Hepatol       Date:  1998-10       Impact factor: 25.083

Review 8.  Hepatorenal syndrome.

Authors:  Pere Ginès; Mónica Guevara; Vicente Arroyo; Juan Rodés
Journal:  Lancet       Date:  2003-11-29       Impact factor: 79.321

9.  Renal duplex Doppler ultrasonography: a noninvasive predictor of kidney dysfunction and hepatorenal failure in liver disease.

Authors:  J F Platt; J H Ellis; J M Rubin; R M Merion; M R Lucey
Journal:  Hepatology       Date:  1994-08       Impact factor: 17.425

10.  Diagnosis of functional kidney failure of cirrhosis with Doppler sonography: prognostic value of resistive index.

Authors:  A Maroto; A Ginès; J Saló; J Clària; P Ginès; L Anibarro; W Jiménez; V Arroyo; J Rodés
Journal:  Hepatology       Date:  1994-10       Impact factor: 17.425
View more
  1 in total

1.  Acute-on-chronic liver failure: recent update.

Authors:  Azeem Alam; Ka Chun Suen; Daqing Ma
Journal:  J Biomed Res       Date:  2017-07-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.